000			01731nam a2200385 a 4500
001			ebr10680870
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			100419s2010 nyua sb 001 0 eng d
010			_z 2010016659
020			_z9781616689773 (softcover)
020			_z9781617286308 (e-book)
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)698081866
050	1	4	_aRM345 _b.C55 2010eb
082	0	4	_a616.1/22061 _222
100	1		_aChirkov, Yuliy Y.
245	1	0	_aBeneficial effects of perhexiline in cardiovascular disease states _h[electronic resource] / _cYuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz.
260			_aNew York : _bNova Biomedical/Nova Science Publishers, _c2010.
300			_aviii, 43 p. : _bill. (some col.).
490	1		_aCardiology research and clinical developments
504			_aIncludes bibliographical references (p. [31]-38) and index.
505	0		_aClinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aPerhexiline _xTherapeutic use.
650		0	_aAngina pectoris _xChemotherapy.
650		0	_aCardiovascular agents.
655		7	_aElectronic books. _2local
700	1		_aSverdlov, Aaron L.
700	1		_aHorowitz, John D.
710	2		_aebrary, Inc.
830		0	_aCardiology research and clinical developments series.
856	4	0	_uhttp://site.ebrary.com/lib/rucke/Doc?id=10680870 _zAn electronic book accessible through the World Wide Web; click to view
999			_c60268 _d60268